The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: MESALAMINE.     Injury: Hepatosplenic T-cell lymphoma     Quarter: 2016Q3

Total Records: 12     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
127363891 MESALAMINE. Hepatosplenic T-cell lymphoma RANBAXY 24.00 YR M 0 20160913 US
127363941 MESALAMINE. Hepatosplenic T-cell lymphoma RANBAXY 31.00 YR M 0 20160913 COUNTRY NOT SPECIFIED
127407411 MESALAMINE. Hepatosplenic T-cell lymphoma RANBAXY 22.00 YR M 0 20160914 US
127408601 MESALAMINE. Hepatosplenic T-cell lymphoma RANBAXY 17.00 YR F 0 20160914 US
127408631 MESALAMINE. Hepatosplenic T-cell lymphoma RANBAXY 18.00 YR M 0 20160914 US
127408651 MESALAMINE. Hepatosplenic T-cell lymphoma RANBAXY 19.00 YR M 0 20160914 US
127408671 MESALAMINE. Hepatosplenic T-cell lymphoma RANBAXY 31.00 YR M 0 20160914 US
127408681 MESALAMINE. Hepatosplenic T-cell lymphoma RANBAXY 19.00 YR M 0 20160914 US
127408691 MESALAMINE. Hepatosplenic T-cell lymphoma RANBAXY 20.00 YR M 0 20160914 US
127408701 MESALAMINE. Hepatosplenic T-cell lymphoma RANBAXY 15.00 YR M 0 20160914 US
127408711 MESALAMINE. Hepatosplenic T-cell lymphoma RANBAXY 13.00 YR M 0 20160914 US
127408721 MESALAMINE. Hepatosplenic T-cell lymphoma RANBAXY 12.00 YR M 0 20160914 US

Total Records: 12     Number of Pages: 1